Anti-Aβ globulomer 7C6 antibodies
First Claim
1. An antibody selected from the group consisting of an isolated antibody, a monoclonal antibody and a recombinant antibody, wherein(a) said antibody has a binding affinity to an Aβ
- (20-42) globulomer that is greater than the binding affinity of the antibody to an Aβ
(1-42) globulomer;
(b) the binding affinity of the antibody to the Aβ
(20-42) globulomer is at least 10 times greater than the binding affinity of the antibody to the Aβ
(1-42) globulomer;
(c) the antibody is humanized and binds to the same epitope as a monoclonal antibody 7C6 obtainable from a hybridoma designated by American Type Culture Collection deposit number PTA-7240;
(d) the antibody comprises (i) a VH 7C6 CDR1 consisting of amino acid residues 31-35 of SEQ ID NO;
11, (ii) a VH 7C6 CDR2 consisting of amino acid residues 50-65 of SEQ ID NO;
11, (iii) a VH 7C6 CDR3 consisting of amino acid residues 98-107 of SEQ ID NO;
11, (iv) a VL 7C6 CDR1 consisting of amino acid residues 24-39 of SEQ ID NO;
12, (v) a VL 7C6 CDR2 consisting of amino acid residues 55-61 of SEQ ID NO;
12, and (vi) a VL 7C6 CDR3 consisting of amino acid residues 94-102 of SEQ ID NO;
12.
2 Assignments
0 Petitions
Accused Products
Abstract
Anti-Aβ globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies.
The present invention relates to anti-Aβ globulomer antibodies having a binding affinity to Aβ(20-42) globulomer that is greater than the binding affinity of the antibody to Aβ(1-42) globulomer, antigen-binding moieties thereof, hybridomas producing said antibodies, nucleic acids encoding said antibodies, vectors comprising said nucleic acids, host cells comprising said vectors, methods of producing said antibodies, compositions comprising said antibodies, therapeutic and diagnostic uses of said antibodies and corresponding methods relating to Alzheimer'"'"'s disease and other amyloidoses.
403 Citations
14 Claims
-
1. An antibody selected from the group consisting of an isolated antibody, a monoclonal antibody and a recombinant antibody, wherein
(a) said antibody has a binding affinity to an Aβ - (20-42) globulomer that is greater than the binding affinity of the antibody to an Aβ
(1-42) globulomer;(b) the binding affinity of the antibody to the Aβ
(20-42) globulomer is at least 10 times greater than the binding affinity of the antibody to the Aβ
(1-42) globulomer;(c) the antibody is humanized and binds to the same epitope as a monoclonal antibody 7C6 obtainable from a hybridoma designated by American Type Culture Collection deposit number PTA-7240; (d) the antibody comprises (i) a VH 7C6 CDR1 consisting of amino acid residues 31-35 of SEQ ID NO;
11, (ii) a VH 7C6 CDR2 consisting of amino acid residues 50-65 of SEQ ID NO;
11, (iii) a VH 7C6 CDR3 consisting of amino acid residues 98-107 of SEQ ID NO;
11, (iv) a VL 7C6 CDR1 consisting of amino acid residues 24-39 of SEQ ID NO;
12, (v) a VL 7C6 CDR2 consisting of amino acid residues 55-61 of SEQ ID NO;
12, and (vi) a VL 7C6 CDR3 consisting of amino acid residues 94-102 of SEQ ID NO;
12. - View Dependent Claims (2, 3, 4, 5)
- (20-42) globulomer that is greater than the binding affinity of the antibody to an Aβ
-
6. An antibody selected from the group consisting of an isolated antibody, a monoclonal antibody and a recombinant antibody, wherein said antibody comprises two variable domains, wherein said two variable domains are SEQ ID NO:
- 11 and SEQ ID NO;
12. - View Dependent Claims (7, 8, 9, 10, 11, 12)
- 11 and SEQ ID NO;
-
13. Monoclonal antibody (7C6) obtainable from a hybridoma designated by American Type Culture Collection deposit number PTA-7240.
-
14. Hybridoma designated by an American Type Culture Collection deposit number PTA-7240.
Specification